Search results
Barinthus Biotherapeutics Reports Significant Financial Shifts and Clinical Progress in 2023
GuruFocus.com via Yahoo Finance· 6 days agoNotably, the company reported positive data from its HBV and HPV programs, initiated the first...
New COVID-Like Outbreak 'Matter Of When, Not If,' WHO Director Warns As Scientists Race To Prepare...
Benzinga via Yahoo Finance· 1 week agoThe 2020 COVID-19 outbreak caused massive human suffering, job loss, disruption and financial market...
Jiangsu Recbio Technology Co., Ltd. announced 2023 annual results report and latest progress
FOX 59 Indianapolis· 1 week agoInnovative vaccine company Recbio (02179.HK) announced its latest progress and annual results for...
Small Business - Shelby County Reporter | Shelby County Reporter
The Shelby County Reporter· 1 week agoSaint-Herblain (France), March 21, 2024 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced it will present on its single-shot chikungunya vaccine, IXCHIQ®, moderate a roundtable on the Zika and chikungunya